Effective treatment of an orthologous model of autosomal dominant polycystic kidney disease
Nature Medicine2004Vol. 10(4), pp. 363–364
Citations Over TimeTop 1% of 2004 papers
Related Papers
- → Long-Term Safety of Tolvaptan in ADPKD(2020)4 cited
- → Long-term Tolvaptan Treatment of Autosomal Dominant Polycystic Kidney Disease in Korea(2018)1 cited
- → SUN-370 TOLVAPTAN USE IN YOUNG ADULTS WITH RAPIDLY PROGRESSING AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE(2020)1 cited
- → Transcriptomic and metabolic profiling of Tolvaptan treated Autosomal dominant polycystic kidney disease (ADPKD) patient(2022)
- → #5882 BENEFIT OF LONG-TERM TOLVAPTAN ADMINISTRATION ON KIDNEY DISEASE PROGRESSION IN AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE: A SINGLE-CENTRE EXPERIENCE(2023)